Institutional Ethics Committee

IEC Chairperson:
Dr. Devendra K. Taneja, M.B.B.S, D.Orth, M.S. (Orthopedic) F.A.M.S, FRCS (Eng.) Medical Director & Senior Consultant (Orthopaedics), Arihant Hospital & Research Centre, Indore.

IEC Member Secretary:
Dr. Kehri Agrawal, M.B.B.S, F.C.C.C.M, F.I.C.M, Senior Intensivist, CHL-Hospitals.
‍
‍IEC Coordinator:
Ms. Janhvi Yadav, B. Pharmacy
WHAT WE DO:
Institutional Ethics Committee is an independent body formally designated to review, approve, and monitor biomedical and behavioral research involving humans with the aim to protect the rights and welfare of the participants. It is constituted of medical, non-medical, scientific and non-scientific members whose responsibility is to ensure the protection of the rights, safety and well-being of human participants involved in any research by, among other things, reviewing, approving and providing continuing review of trial protocols and amendments and to provide public assurance of that protection. Timely reviews and safeguarding of high ethical standards formed the basis of the IEC review process which are essential for clinical research including student research, investigator initiated research and multi-center, multinational research. IEC, CHL-Hospitals became functional in October 2006. IEC registered with Drug Controller General of India, under Central Drugs Standards Control Organization (CDSCO) in 2013-2014 and is periodically renewed as per regulations.

HIGHLIGHTS:

Integrity Ethics Committee, CHL-Hospitals is Madhya Pradesh's first NABH accredited Institutional Ethics Committee.
‍
‍‍‍NABH accreditation: EC-CT-2018-0036; 22 July 2018 to 21 July 2021; 22 July 2021 to 21 July 2024
‍
Ethics Committee Registration Number: With CDSCO: ECR/505/Inst/MP/2014/RR-20; 31 March 2020 - 30 March 2025

Department of Health Research (NAITIK): Provisional Registration - EC/NEW/INST/2020/487 ; 7 July 2020 - 6 July 2022
‍

IEC REVIEW PROCESS

Investigator is required to submit documents to Institutional Ethics Committee (IEC) at least 3 weeks prior to IEC meeting.

The Institutional Ethics Committee member(s) will consider the following criteria when performing the review of the study protocol:

• Minimize risks to participants;
• Risks must be reasonable in relation to anticipated benefits;
• Participants are selected equitably;
• Informed consent is adequate, easy to understand and properly documented;
• The research plan makes adequate provision for monitoring the data collected to ensure the safety of participants, where appropriate;
• There are adequate provisions to protect the privacy of participants and to maintain the confidentiality of data, where appropriate;
• Appropriate safeguards are included to protect vulnerable participants;
• Ensure that the advertisements regarding the research project do not induce the participants to be lured into the clinical trials and that Research doctor has a recruitment policy to ensure unbiased selection of adequate number of suitable subjects according to the protocol.

IEC COMMUNICATION DETAILS:
Ethics Committee Coordinator, Integrity Ethics Committee, CHL-Hospitals
(A Unit of Convenient Hospitals Ltd.)
Near L. I. G. Square, A. B. Road, Indore-452008, Madhya Pradesh, India.
Tel: 0731-4774146
Email: iec@chlhospitals.com